🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Mounjaro KwikPen vs vial — looking for input Page 5

Mounjaro KwikPen vs vial — looking for input

tony_orlando Sat, Oct 19, 2024 at 1:14 AM 33 replies 2,392 viewsPage 5 of 7
kim_atl_prep
Member
312
1,345
Aug 2024
Atlanta, GA
Oct 26, 2024 at 6:36 PM#21
PharmacoVig_BOS said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Right, and the exception is worth naming rather than left implied, because the exception is where people get into trouble.

21 19PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 18 others
Reply Quote Save Share Report
LondonLisa
Member
912
3,456
Mar 2024
London, UK
Oct 28, 2024 at 3:29 PM#22
PharmacoVig_BOS said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Saving this. It is the first explanation that did not require me to already understand it.

Last edited: Oct 28, 2024 at 5:29 PM
22 20Dr.MetabolicMD, RetaRick_CA, JenPlateau and 19 others
Reply Quote Save Share Report
Dr.MetabolicMD
VIP Member
2,345
16,789
Jan 2024
Rochester, MN
Oct 30, 2024 at 12:23 PM#23

Clinical perspective, offered as context rather than as advice. The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either. Those three things can all be true at once, and most arguments here are two people holding different parts of that.

23 21HealthEcon_DC, PedsEndoPhilly, SleepDoc_PDX and 20 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
KevinCompounds
VIP Member
5,432
18,234
Dec 2023
Nevada
Nov 1, 2024 at 9:18 AM#24
Dr.MetabolicMD said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

This is my experience too, for whatever a second data point is worth.

Last edited: Nov 1, 2024 at 11:18 AM
24 22BenResearch_OR, MikeKY_noInsulin, Dr.RaviCardio and 21 others
Reply Quote Save Share Report
pam_stl
Member
267
1,123
Oct 2024
St. Louis, MO
Nov 3, 2024 at 6:14 AM#25
Dr.MetabolicMD said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

There is a second half to this that has not been said yet. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

Last edited: Nov 3, 2024 at 11:14 AM
25 23RegAffairsDC, BiostatsBrad, PeptideSynthNJ and 22 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register